Doojduen Villaluna

Xuexia Wang, University of North Texas, Denton, TX; Can-Lan Sun, City of Hope, Duarte; Leo Mascarenhas, Children's Hospital Los Angeles, University of Southern California, Los Angeles; Doojduen Villaluna, Children's Oncology Group, Monrovia, CA; Lindsey Hageman, Kandice Smith, Purnima Singh, Wendy Landier, and Smita Bhatia, University of Alabama at Birmingham, Birmingham, AL; Sunil Desai, University of Alberta, Edmonton, Alberta, Canada; Douglas S. Hawkins, Seattle Children's Hospital, University of Washington, Fred Hutchinson Cancer Research Center, Seattle, WA; Melissa M. Hudson and Leslie L. Robison, St Jude Children's Research Hospital, Memphis, TN; Joseph P. Neglia, University of Minnesota Medical School, Minneapolis, MN; Kevin C. Oeffinger, Duke University Medical Center, Durham, NC; and A. Kim Ritchey, University of Pittsburgh School of Medicine, Pittsburgh, PA.

View Article and Find Full Text PDF

November 2017

Reduced and Compressed Cisplatin-Based Chemotherapy in Children and Adolescents With Intermediate-Risk Extracranial Malignant Germ Cell Tumors: A Report From the Children's Oncology Group.

Authors:

Furqan Shaikh John W Cullen Thomas A Olson Farzana Pashankar Marcio H Malogolowkin James F Amatruda Doojduen Villaluna Mark Krailo Deborah F Billmire Frederick J Rescorla Rachel A Egler Bryan J Dicken Jonathan H Ross Marc Schlatter Carlos Rodriguez-Galindo A Lindsay Frazier

J Clin Oncol 2017 Apr 27;35(11):1203-1210. Epub 2017 Feb 27.

Furqan Shaikh, The Hospital for Sick Children, University of Toronto, Toronto, Canada; John W. Cullen, Rocky Mountain Hospital for Children-Presbyterian Saint Luke's Medical Center, Denver, CO; Thomas A. Olson, Children's Healthcare of Atlanta, and Emory University, Atlanta, GA; Farzana Pashankar, Yale University School of Medicine, New Haven, CT; Marcio H. Malogolowkin, University of California Davis Comprehensive Cancer Center, Sacramento; Doojduen Villaluna and Mark Krailo, Children's Oncology Group, Monrovia; Mark Krailo, University of Southern California, Los Angeles, CA; James F. Amatruda, University of Texas Southwestern Medical Center and Children's Medical Center Dallas, Dallas, TX; Deborah F. Billmire and Frederick J. Rescorla, Riley Hospital for Children, Indianapolis, IN; Rachel A. Egler and Jonathan H. Ross, Rainbow Babies and Children's Hospital, Cleveland, OH; Bryan J. Dicken, Stollery Children's Hospital, and University of Alberta Hospital, Edmonton, Alberta, Canada; Marc Schlatter, Helen DeVos Children's Hospital at Spectrum Health, Grand Rapids, MI; Carlos Rodriguez-Galindo, St Jude Children's Research Hospital, Memphis, TN; and A. Lindsay Frazier, Dana-Farber Cancer Institute and Boston Children's Hospital, Boston, MA.

View Article and Find Full Text PDF

April 2017

Systemic neoadjuvant chemotherapy for Group B intraocular retinoblastoma (ARET0331): A report from the Children's Oncology Group.

Authors:

Debra L Friedman Mark Krailo Doojduen Villaluna Dan Gombos Bryan Langholz Rima Jubran Carol Shields Linn Murphree Joan O'Brien Sandra Kessel Carlos Rodriguez-Galindo Murali Chintagumpala Anna T Meadows

Pediatr Blood Cancer 2017 Jul 26;64(7). Epub 2016 Dec 26.

The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.

View Article and Find Full Text PDF

July 2017

Effects of sodium thiosulfate versus observation on development of cisplatin-induced hearing loss in children with cancer (ACCL0431): a multicentre, randomised, controlled, open-label, phase 3 trial.

Authors:

David R Freyer Lu Chen Mark D Krailo Kristin Knight Doojduen Villaluna Bonnie Bliss Brad H Pollock Jagadeesh Ramdas Beverly Lange David Van Hoff Michele L VanSoelen John Wiernikowski Edward A Neuwelt Lillian Sung

Lancet Oncol 2017 01 1;18(1):63-74. Epub 2016 Dec 1.

Hematology/Oncology, Hospital for Sick Children, Toronto, ON, Canada.

View Article and Find Full Text PDF

January 2017

Assessment of extent of surgical resection of primary high-grade osteosarcoma by treating institutions: A report from the Children's Oncology Group.

Authors:

Carol D Morris Lisa A Teot Mark L Bernstein Neyssa Marina Mark D Krailo Doojduen Villaluna Katherine A Janeway Steven G DuBois Richard G Gorlick Robert Lor Randall

J Surg Oncol 2016 Mar 18;113(4):351-4. Epub 2016 Jan 18.

Department of Orthopaedics, Huntsman Cancer Institute, University of Utah School of Medicine, Salt Lake City, Utah.

View Article and Find Full Text PDF

March 2016

Pilot Study of Adding Vincristine, Topotecan, and Cyclophosphamide to Interval-Compressed Chemotherapy in Newly Diagnosed Patients With Localized Ewing Sarcoma: A Report From the Children's Oncology Group.

Authors:

Leo Mascarenhas Judy L Felgenhauer Mason C Bond Doojduen Villaluna Joseph Dominic Femino Nadia N Laack Sarangarajan Ranganathan James Meyer Richard B Womer Richard Gorlick Mark D Krailo Neyssa Marina

Pediatr Blood Cancer 2016 Mar 18;63(3):493-8. Epub 2015 Nov 18.

Lucille Packard Children's Hospital, Stanford University School of Medicine, Palo Alto, California.

View Article and Find Full Text PDF

March 2016

Rapid Protocol Enrollment in Osteosarcoma: A Report From the Children's Oncology Group.

Authors:

Michael S Isakoff Robert Goldsby Doojduen Villaluna Mark D Krailo Richard Gorlick John J Doski Richard B Womer Katherine A Janeway

Pediatr Blood Cancer 2016 Feb 16;63(2):370-1. Epub 2015 Sep 16.

Department of Pediatric Oncology, Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, Massachusetts.

View Article and Find Full Text PDF

February 2016

Feasibility Study of a Novel Experimental Induction Protocol Combining B43-PAP (Anti-CD19) Immunotoxin With Standard Induction Chemotherapy in Children and Adolescents With Relapsed B-Lineage ALL: A Report From the Children's Oncology Group.

Authors:

Holly J Meany Nita L Seibel Mark Krailo Doojduen Villaluna Zhengjia Chen Paul Gaynon Joseph P Neglia Julie R Park Raymond Hutchinson Judith K Sato Robert J Wells William G Woods Gregory Reaman

J Immunother 2015 Sep;38(7):299-305

*Department of Pediatric Hematology-Oncology, Children's National Medical Center, George Washington University School of Medicine and Public Health, Washington, DC †Clinical Investigations Branch, Cancer Therapy Evaluation Program, NCI, Bethesda ¶¶Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD ‡Keck School of Medicine, University of Southern California ¶Division of Hematology-Oncology, Children's Hospital Los Angeles, Los Angeles §Children's Oncology Group, Arcadia ‡‡Department of Pediatrics, City of Hope National Medical Center, Duarte, CA ∥Department of Biostatistics and Bioinformatics, Emory University ∥∥Aflac Cancer and Blood Disorder Center, Children's Healthcare of Atlanta/Emory University, Atlanta, GA #Department of Pediatrics, University of Minnesota Medical School, Minneapolis, MN **Department of Pediatrics, Seattle Children's Hospital, University of Washington, Seattle, WA ††Pediatric Hematology-Oncology, C.S. Mott Children's Hospital, Ann Arbor, MI §§Division of Pediatrics, Children's Cancer Hospital at the University of Texas M.D. Anderson Cancer Center, Houston, TX.

View Article and Find Full Text PDF

September 2015

Surveillance after initial surgery for Stage I pediatric and adolescent boys with malignant testicular germ cell tumors: Report from the Children's Oncology Group.

Authors:

Frederick J Rescorla Jonathan H Ross Deborah F Billmire Bryan J Dicken Doojduen Villaluna Mary M Davis Mark Krailo John W Cullen Thomas A Olson Rachel A Egler James F Amatruda Carlos Rodrigues-Galindo A Lindsey Frazier

J Pediatr Surg 2015 Jun 14;50(6):1000-3. Epub 2015 Mar 14.

Dana-Farber Cancer Institute, USA.

View Article and Find Full Text PDF

June 2015

Surveillance after initial surgery for pediatric and adolescent girls with stage I ovarian germ cell tumors: report from the Children's Oncology Group.

Authors:

Deborah F Billmire John W Cullen Frederick J Rescorla Mary Davis Marc G Schlatter Thomas A Olson Marcio H Malogolowkin Farzana Pashankar Doojduen Villaluna Mark Krailo Rachel A Egler Carlos Rodriguez-Galindo A Lindsay Frazier

J Clin Oncol 2014 Feb 6;32(5):465-70. Epub 2014 Jan 6.

Deborah F. Billmire and Frederick J. Rescorla, Riley Hospital for Children, Indianapolis, IN; John W. Cullen, Rocky Mountain Hospital for Children-Presbyterian St Luke's Medical, Denver, CO; Mary Davis and Marc G. Schlatter, Helen DeVos Children's Hospital at Spectrum Health, Grand Rapids, MI; Thomas A. Olson, Children's Healthcare of Atlanta, Emory University, Atlanta, GA; Marcio H. Malogolowkin, Children's Hospital of Wisconsin, Medical College of Wisconsin, Milwaukee, WI; Farzana Pashankar, Yale University, New Haven, CT; Doojduen Villaluna, Children's Oncology Group, Monrovia; Mark Krailo, Keck School of Medicine, University of Southern California, Los Angeles, CA; Rachel A. Egler, Rainbow Babies and Children's Hospital, Cleveland, OH; and Carlos Rodriguez-Galindo and A. Lindsay Frazier, Dana-Farber Cancer Institute and Boston Children's Hospital, Boston, MA.

View Article and Find Full Text PDF

February 2014